Solid Biosciences Tracks Long-Term Effects of Duchenne Muscular Dystrophy Gene Therapy

Date

Share Now

Solid Biosciences is monitoring the long-term effects of gene therapy for Duchenne muscular dystrophy, reporting promising data from Phase 1/2 IGNITE-DMD studies. (September 9, 2024)

Source: CGTlive™

Tags :